Matthews International Capital Management LLC Adc Therapeutics Sa Transaction History

Matthews International Capital Management LLC

  • $589 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021
SELL
$20.38 - $27.04 $12.4 Million - $16.4 Million
-607,800 Closed
0 $0
Q1 2021

May 06, 2021
BUY
$22.75 - $34.05 $8.38 Million - $12.5 Million
368,300 Added 153.78%
607,800 $14.8 Million
Q2 2020

Jul 29, 2020
BUY
$29.65 - $46.81 $7.1 Million - $11.2 Million
239,500 New
239,500 $11.2 Million

Others Institutions Holding ADCT

# of Institutions
80
Shares Held
55.1M
Call Options Held
82.7K
Put Options Held
31.5K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $152M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Matthews International Capital Management LLC Portfolio

Follow Matthews International Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email